Cudetaxestat (BLD-0409) ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
85	特発性間質性肺炎	1

85. 特発性間質性肺炎

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05373914 (ClinicalTrials.gov)	May 31, 2022	10/5/2022	RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF) ...	RESPIRARE - A Phase 2, Randomized, Double-blinded, Placebo-controlled, Efficacy and Safety Study of ...	Idiopathic Pulmonary Fibrosis	Drug: Cudetaxestat (BLD-0409);Drug: Control: Matching Placebo	Blade Therapeutics	NULL	Not yet recruiting	40 Years	85 Years	All	200	Phase 2	NULL

First Previous1Next Last